26 June 2003

FDA unlikely to seek labels on cloned animal meat, milk
By Randy Fabi, Reuters

WASHINGTON — U.S. consumers will most likely not know when they buy hamburgers, bacon, and milk products from cloned animals, a technology that could be available by next year, government and industry officials said Wednesday.

John Matheson, regulatory review scientist at the Food and Drug Administration, said the agency would not require labels on cloned animal products if they are considered as safe as traditional food.

"If we find no problems with the products, we have no legal basis to require labels or have companies differentiate between them," he said at an annual biotech industry conference.

Cloned animals, such as cattle, sheep, and poultry, can be farmed to provide more milk or eggs than their counterparts. Researchers also can enhance the nutritional value of food, including lowering cholesterol in eggs and producing  leaner meat with enhanced vitamin content.

A cloned calf can sell for as much as $82,000.

The FDA was expected to release its risk assessment concerning the new technology later this summer. The report will be the foundation for new FDA guidelines, which could allow these products to be available by next year.

"These products are perfectly safe," said Steven Stice, chief scientific officer of Georgia-based ProLinia Inc. "There's no need for labels."

The privately owned company, which sells cloned cows and pigs, was in discussions with mega-pork producer Smithfield Foods Inc., Stice said.

Last year, the National Academy of Sciences found no significant health risks from cloned animal products. The report did recommend stronger U.S. government oversight to ensure its safety.

Joe Mendelson, legal director for the Center for Food Safety, said it hoped FDA would allow consumers to make a choice on whether to purchase cloned meat.

"I certainly think consumer views are material and should be a legal basis for labeling," he said.

How consumers react to cloned animal meat could significantly influence the commercialization of future biotech products.

Erik Forsberg, vice president of Wisconsin-based Infigen Inc., said consumer acceptance of cloned animal meat would help alleviate fears surrounding xenotransplants. The privately owned company produces cloned cows and pigs in hopes of selling its organs for human use.

Source: Reuters